Morfina sulfate 30 mg is a potent opioid analgesic commonly available in immediate-release (IR) oral tablets, extended-release (ER) formulations (e.g., MS Contin), or other forms like injections. Here’s a factual breakdown based on standard pharmacological data (e.g., from FDA labels, USP, and medical references like Lexicomp):

Principali Utilizzi

• Primario: Moderate to severe pain relief (e.g., post-surgical, cancer pain, acute injury).
• Altro: Sometimes for severe dyspnea in palliative care or cough suppression.
• 30 mg dose context:

Farmacocinetica

• Biodisponibilità: ~20-30% oral (first-pass metabolism); 100% IV.
• Metà vita: 2-4 hours (normal renal/hepatic function).
• Equianalgesic dose: 30 mg oral IR ≈ 10 mg IV/IM ≈ 30 mg rectal.

Dosing Guidelines (Adults)

• Bambini: Weight-based (0.05-0.2 mg/kg IV); not for <2 yrs typically.
• Conversion: From other opioids, use calculators like those from MDCalc (e.g., 30 mg morphine oral = 10 mg IV).

Effetti collaterali e rischi

• Controindicazioni: Acute asthma, paralytic ileus, severe respiratory depression.
• Avvertenze: High abuse potential (Schedule II controlled substance). Risk of addiction, overdose (esp. with benzos/alcohol). CDC guidelines recommend lowest effective dose/shortest duration.

Prove e fonti

• Efficacia: Supported by RCTs (e.g., WHO pain ladder); 30 mg IR provides ~70-90% pain reduction in opioid-naive patients (JAMA reviews).
• References: FDA label (morphine sulfate), UpToDate, Micromedex. For calculations: Opioid Equianalgesic Table (Palliative Care Network).

Disclaimer: This is general info, not medical advice. Dosing must be personalized by a healthcare provider. Misuse can be fatal—consult a doctor/pharmacist. If this is for a specific scenario, provide more details for tailored facts.